Hepatitis C Prevalence and Injection Drug Use in Greece

"According to DRID data, HCV antibody prevalence in IDUs has been consistently high and increasing over the last 10 years in Greece. In 2011, prevalence rates ranged between 62.4% and 79.3%, depending on the source of data (Figure 6.4). Compared to 2010, in 2011 HCV infection rates remained stable in data source 1 (national sample), but increased significantly in data sources 2 (national sample) and 3 (Athens sample) (Figure 6.4)."


University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 96.